相关实验视频

Updated: Jun 15, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

多发性骨髓瘤细胞疗法的新方法:专注于化学抗原受体T细胞

Ravi Kishore Narra¹, Supriya Peshin², Binod Dhakal¹

¹Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

Acta haematologica

|December 29, 2024

概括

化学抗原受体T细胞 (CAR-T) 疗法对多发性骨髓瘤具有前景,但毒性和耐药性等挑战仍然存在. 目前正在进行的研究重点是新的策略,以提高这些先进的细胞疗法的安全性,疗效和适用性.

科学领域:

血液学血液学血液学
免疫学免疫学免疫学
在瘤学瘤学.

背景情况:

化学抗原受体T细胞 (CAR-T) 疗法和双特异性抗体已经改变了多发性骨髓瘤治疗.
两种针对BCMA的CAR-T产品已获得FDA批准,在预先治疗的患者中显示出有效性.
挑战包括可访问性,细胞因子释放综合征,神经毒性和通过抗原损失或T细胞枯竭的耐药性.

研究的目的:

审查目前用于多发性骨髓瘤的CAR-T疗法的安全性和有效性.
讨论与CAR-T疗法相关的现有挑战.
突出正在进行的研究,解决局限性和完善疗法.

主要方法:

对多发性骨髓瘤CAR-T疗法的当前文献的综述.
对已批准的CAR-T产品的安全性和有效性数据的分析.
探索新的战略和新兴目标.

主要成果:

对于多发性骨髓瘤患者来说,CAR-T疗法具有显著的益处.
目前的疗法面临着与毒性,耐药性和可访问性相关的挑战.
正在研究诸如全基CAR-T,CAR-NK细胞和装甲CAR-T等创新方法.

结论:

卡尔-T细胞疗法是多发性骨髓瘤治疗的重大进展.
克服挑战需要新的战略和结构性修改.
未来的研究旨在提高安全性,扩大适用性,并实现长时间的疗效.

关键词:

在CART-T中,我们可以使用CAR-T.骨髓瘤是多发性骨髓瘤的一种.新型免疫疗法新型免疫疗法

更多相关视频

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...